Market · Germany · Medical THC
Europe’s largest medical cannabis market, regulated as pharma.
Germany is the largest medical cannabis market in Europe. AMP GmbH, a fully licensed EU pharmaceutical distributor, gives Essence direct access to this market.
GMP + GDP
AMP GmbH holds full EU pharmaceutical licences for import, manufacture and distribution
9
GMP-qualified suppliers in Thailand, Czech Republic and Denmark
1.3 t
Medical cannabis flower distributed by AMP in Q1 2026
Market overview
Detailed Germany medical-THC market overview coming shortly.
Germany legalised medical cannabis in 2017 and has developed into Europe’s largest regulated medical cannabis market. The market is served through a pharmaceutical distribution framework requiring GMP and GDP licences.
Full market copy for this page is being prepared and will be published shortly. In the meantime, please refer to the AMP GmbH portfolio page for details of Essence’s German operations.
A regulated industry deserves a regulated investor.
Essence Investment AG · Switzerland
Get in touch